Prolotherapy is a frequently misunderstood but clinically valuable treatment for sacroiliac joint dysfunction — particularly in patients with ligament laxity or hypermobility. This episode breaks down the mechanism of action, compares glucose and platelet-rich plasma (PRP) as injectants, and covers patient selection criteria, the diagnostic process, potential risks, and realistic outcomes. Whether a patient is dealing with SIJ instability, hEDS-related laxity, or chronic pelvic pain, this episode provides a clear, evidence-informed look at when and how prolotherapy is most effective.
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Dan Bates & Justine Feitelson. Innehållet i podden är skapat av Dr. Dan Bates & Justine Feitelson och inte av,
eller tillsammans med, Poddtoppen.